Exome Sequencing Reveals De Novo WDR45 Mutations Causing a Phenotypically Distinct, X-Linked Dominant Form of NBIA  by Haack, Tobias B. et al.
REPORT
Exome Sequencing Reveals De Novo
WDR45 Mutations Causing a Phenotypically
Distinct, X-Linked Dominant Form of NBIA
Tobias B. Haack,1,2 Penelope Hogarth,3,4 Michael C. Kruer,5 Allison Gregory,4 Thomas Wieland,2
Thomas Schwarzmayr,2 Elisabeth Graf,2 Lynn Sanford,4 Esther Meyer,6,7 Eleanna Kara,8,9
Stephan M. Cuno,1,2 Sami I. Harik,10 Vasuki H. Dandu,10 Nardo Nardocci,11 Giovanna Zorzi,11
Todd Dunaway,12 Mark Tarnopolsky,13 Steven Skinner,14 Steven Frucht,15 Era Hanspal,16,17
Connie Schrander-Stumpel,18 Delphine He´ron,19 Cyril Mignot,19 Barbara Garavaglia,20 Kailash Bhatia,21
John Hardy,8,9 Tim M. Strom,1,2 Nathalie Boddaert,22 Henry H. Houlden,8 Manju A. Kurian,6,7
Thomas Meitinger,1,2 Holger Prokisch,1,2 and Susan J. Hayflick3,4,23,*
Neurodegenerationwith brain iron accumulation (NBIA) is a group of genetic disorders characterized by abnormal iron deposition in the
basal ganglia. We report that de novo mutations in WDR45, a gene located at Xp11.23 and encoding a beta-propeller scaffold protein
with a putative role in autophagy, cause a distinctive NBIA phenotype. The clinical features include early-onset global developmental
delay and further neurological deterioration (parkinsonism, dystonia, and dementia developing by early adulthood). BrainMRI revealed
evidence of iron deposition in the substantia nigra and globus pallidus. Males and females are phenotypically similar, an observation
that might be explained by somatic mosaicism in surviving males and germline or somatic mutations in females, as well as skewing
of X chromosome inactivation. This clinically recognizable disorder is among the more common forms of NBIA, and we suggest that
it be named accordingly as beta-propeller protein-associated neurodegeneration.Neurodegeneration with brain iron accumulation (NBIA)
comprises a set of single-gene disorders that manifest
as a range of neurological phenotypes and share the fea-
ture of high levels of basal-ganglia iron.1 To date, the major
genes associated with NBIA include PANK2 (MIM 606157),
C19orf12 (MIM 614297), and PLA2G6 (MIM 603604),
which encode mitochondria-associated proteins with no
clear link to iron homeostasis. Mutations in these genes
lead to autosomal-recessive degenerative disorders affect-
ing children and adults.
As specific genetic forms of NBIA were identified,
a distinctive phenotype became evident among the re-
maining idiopathic cohort.2 A subset of study participants
had global developmental delay in early childhood and
slow motor and cognitive gains until adolescence or early
adulthood, when dystonia, parkinsonism, and dementia
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istic of high iron: a markedly hypointense signal on T2-
weighted sequences in the substantia nigra and globus
pallidus (Figure 1). In addition, cerebral atrophy was
observed. A unique feature of this form of NBIA was T1
hyperintensity surrounding a central linear region of sig-
nal hypointensity within the substantia nigra and cerebral
peduncles (Figure 1), a feature previously suggested to indi-
cate a new NBIA subtype1–3 (also see GeneReviews in Web
Resources).
Among families with affected individuals, none demon-
strated a pattern of Mendelian inheritance of this pheno-
type. Affected individuals were singletons from diverse
ethnic and racial groups without known or suspected
consanguinity. One was male, and 13 were female. The
simplex pattern of disease in families, the similar pheno-
type in both genders, and the absence of male lethalityh, Germany; 2Institute of Human Genetics, Helmholtz Zentrum Mu¨nchen,
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Figure 1. MRI Features Associated with WDR45 Mutations
T2-weighted turbo-spin-echo (TSE) MRI shows (A) a hypointense
signal (arrow) in the globus pallidus, which ‘‘blooms’’ on fluid-
attenuated inversion-recovery sequence (B, arrow), consistent
with iron. A hypointense signal (C, arrow) in the substantia nigra
on T2-weighted TSE shows iron, and T1-weighted imaging
demonstrates a hyperintense halo (D, arrow) in the substantia
nigra.led us to consider autosomal-recessive inheritance and de
novo mutations in an NBIA-associated gene. However,
we remained open to the possibility of X-linked inheri-
tance on the basis of the gender bias in our cohort. We
therefore undertook exome sequencing to identify their
causative mutations. The procedures followed were in
accordance with the ethical standards of the institutional
review board at Oregon Health & Science University, and
proper informed consent was obtained.
Exome sequencing and variant calling were performed
as described previously.4 We used the SureSelect Human
All Exon 50 Mb kit from Agilent for in-solution en-
richment of exonic sequences. Libraries were subsequently
sequenced as 100 bp paired-end runs. Read alignment was
performed with the Burrows-Wheeler Aligner (v.0.5.8).
SAMtools (v.0.1.7) was used for detecting single-nucleotide
variants and small insertions and deletions. We produced
an average of 10.2 Gb of mappable sequences per sample;
the mean was 1233 coverage, and >90% of the exome
was covered >203, enabling high-confidence variant
detection (Table S1, available online).The American JouTo identify the disease-causing mutations, we analyzed
exome sequence in 14 unrelated persons with a homoge-
neous clinical and radiological phenotype; this allowed
us to use a stringent in silico filtering strategy to address
the major challenge of distinguishing disease-causing
mutations from benign sequence variants. To prioritize
candidate genes, we step-wise filtered the identified DNA
variants on the basis of the following assumptions: (1)
Because the disease is rare and severe, we expected the
mutations to alter the protein sequence and to have
a very low frequency in control populations. We excluded
variants with a minor allele frequency > 0.3% in public
SNP databases (HapMap and 1000 Genomes) and in
1,429 exomes. (2) Although we favored de novomutations
exerting their effects in a dominant fashion, we also
considered an autosomal-recessive mode of inheritance.
(3) Given the distinct phenotype of the individuals
studied, we postulated that most would share defects in
the same gene. For the joint analysis of dominant variants,
we excluded highly variable genes with >70 different
rare nonsynonymous variants in 1,414 exomes. Searching
for compound heterozygous or homozygous mutations
yielded approximately ten mutant genes, none of which
were known to be associated with NBIA, per individual
(Table S2). The only gene with compound heterozygous
or homozygous mutations in more than two individuals
was HR (Table 1), considered an unlikely candidate given
its role in hair growth (MIM 203655).
We next searched for single variants affecting the
same gene shared by an increasing number of cases. This
filtering left a single gene with variants identified in
more than five individuals: X chromosomal WDR45
(RefSeq accession number NM_007075.3), which encodes
aWD40 repeat protein. In fact, 13 of 14 individuals carried
a mutated allele, each with a different variant; 11 of these
variants were predicted to cause loss of function, and two
were predicted to change an evolutionarily conserved
amino acid residue (Figure 2). One missense mutation,
c.38G>C, was predicted to change the arginine at position
13 to proline and to skip the first coding exon, leading
to a protein starting with methionine at position 25
(GENSCAN). Mutations in WDR45 were independently
confirmed by Sanger sequencing.
We then broadened our search to include other study
participants with idiopathic NBIA and a suggestive
phenotype. Mutations were found in seven additional
individuals, including two males. Segregation analysis in
the families from which parental DNA was available
revealed only reference alleles of WDR45 in all samples,
indicating that the mutations in the probands were
de novo. In total, 19 mutations were found in 20 sub-
jects, and none were present in parental DNA samples,
arguing for de novo mutations as the de facto mecha-
nism underlying the disease (Table 2). Two affected indi-
viduals harbored an identical mutation (c.1007_1008del
[p.Tyr336Cysfs*5]). Clinical testing for WDR45 mutations
is now available.rnal of Human Genetics 91, 1144–1149, December 7, 2012 1145
Table 1. Identification of the Associated Gene by Joint Analysis of 14 Exomes
Minimal Cases
R2 R3 R4 R5 R6 R13
Dominant-model candidate genes (R1 rare nonsynonymous variant
in the same gene)
>500 224 32 2 (MYLK,WDR45) 1 (WDR45) 1 (WDR45)
Recessive-model candidate genes (R2 rare nonsynonymous variants
in the same gene)
45 1 (HR) 0 0 0 0
In more than 2,000 X chromosomes, only one missense variant, c.763G>T (p.Ala255Ser) (with benign or neutral effects as predicted by in silico analysis by
PolyPhen-2), was identified in WDR45. Loss-of-function alleles were not detected, nor were any found in the National Heart, Lung, and Blood Institute (NHLBI)
Exome Variant Server listing a total of >8,700 alleles. Nonsynonymous variants include missense, nonsense, stop-loss, and splice-site mutations, as well as inser-
tions and deletions. ‘‘Rare’’ indicates a frequency < 0.3% in 1,429 control exomes in the in-house database, HapMap, and the 1000 Genomes project. Genes in
bold are those that carry the causal mutations.WD40 repeat proteins compose a large family of mole-
cules with repeating units containing a conserved core of
40þ amino acids that terminate with tryptophan-as-
partic-acid (WD) residues. WD40 proteins regulate the
assembly of multiprotein complexes to serve diverse
functions including signal transduction, transcriptional
regulation, autophagy, and cell-cycle control.5 The struc-
ture of these proteins is key to their role in orchestrat-
ing protein-protein interactions. WD40 repeat proteins
assume a highly symmetrical, seven-bladed, beta-propeller
platform structure for coordinating protein-protein inter-
actions. WDR45 contains a conservedmotif for interaction
with phospholipids, and the protein binds or associates
with known autophagy proteins ATG2A and ATG2B.5,6
WD40 repeat proteins are defective in other neurologic
disorders.7 Lissencephaly-1 (LIS1 [MIM 607432]) was the
first WD repeat gene identified as the cause of a humanNM_007075.3
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Figure 2. WDR45 Structure and Conservation of Mutated Residues
Exon-intron structure of WDR45 with localization and conservation
the cause of BPAN.
1146 The American Journal of Human Genetics 91, 1144–1149, Decedisease. Also, type A Cockayne syndrome (MIM 216400)
is associated with mutations in a gene encoding a
WD40-repeat-protein family member. Another X-linked
gene, TBL1X (MIM 300196), encodes the protein trans-
ducing-b-like, and its mutations lead to sensorineural deaf-
ness. Finally, achalasia-addisonianism-alacrima syndrome
(MIM 231550) is caused by mutations in a gene encoding
a WD40 repeat protein, aladin. Defective aladin leads to
abnormal development of the autonomic nervous system
and late-onset neurodegeneration. Interestingly, all of
these disorders are characterized by defects in brain devel-
opment or in the maintenance of normal brain function.
Although WDR45 is located on the X chromosome and
undergoes inactivation, the clinical features of this form
of NBIA do not follow a pattern typical of an X-linked
disorder. The phenotype of affected males is indistinguish-
able from that of females; indeed, there is a striking6 7 8 9 10 11 12
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Table 2. Genetic Characteristics of Study Subjects and Family Members
ID Sex Ancestry
WDR45 Mutations Identified Mutation Status of Family Members
cDNA
(RefSeq NM_007075.3)
Protein
(RefSeq NP_009006) Mother Father Sibling (n)
60251 F German, Irish, English, Austrian c.1007_1008del p.Tyr336Cysfs*5 WT WT WT (1)
63700 F German, Sioux, Cherokee c.38G>C p.Arg13Proa WT WT WT (2)
63701 F German, French, Irish c.-1_5del p.Met1? WT N/A N/A
63702 F African American c.293T>C p.Leu98Pro WT N/A WT (1)
63703 F African American c.476del p.Leu159Argfs*2 N/A N/A N/A
63704 F Hispanic, Puerto Rican c.19C>T p.Arg7* N/A N/A N/A
63705 F Romanian, French c.56-1G>A splicing defect N/A N/A N/A
63706 F German, Irish, English c.700C>T p.Arg234* WT N/A WT (4)
63707 F unknown c.400C>T p.Arg134* WT WT WT (3)
63708 M German, Irish, Scottish c.228_229del p.Glu76Aspfs*38 WT WT N/A
63709 F Italian, northern European,
Native American
c.405_409del p.Lys135Asnfs*2 N/A N/A N/A
63711 F Dutch c.359dup p.Lys121Glufs*18 WT WT WT (4)
63712 F Scottish, Irish c.830þ1G>A splicing defect WT WT N/A
49841 M German c.19dup p.Arg7Profs*64 N/A N/A N/A
411-201 F Italian c.235þ1G>A splicing defect WT WT N/A
HH56 F unknown c.1007_1008del p.Tyr336Cysfs*5 WT WT N/A
HH84 F unknown c.694_703del p.Leu232Alafs*53 WT WT N/A
NBIA10 F Pakistani c.183C>A p.Asn61Lys WT WT N/A
463 M English c.1025_1034delinsACATATTT p.Gly342Aspfs*12 N/A N/A N/A
152 F unknown c.55þ1G>C splicing defect WT WT WT (1)
Numbers in parentheses indicate the amount of tested siblings of the proband. The following abbreviations are used: F, female; M, male; WT, wild-type; and N/A,
not available.
aThis alteration is predicted to cause skipping of exon 3 and usage of an alternate start methionine at position 25.uniformity to the clinical features and the natural history
of the disease in all 20 study participants. All three males
harbor a mutation that is predicted to render the protein
nonfunctional, as is also the case for many of the females.
How might this be explained? Sex-chromosome aneu-
ploidy could account for the observations; however,
normal karyotypes were reported on the two males from
whom they were available. Although males could harbor
a separate activating mutation in one of several WDR45
pseudogenes (of which there are at least three) or a tandem
duplication of WDR45 (with a subsequent mutation in
only one gene copy), the more likely explanation is a
postzygotic mutation leading to somatic mosaicism in
males. This mechanism could explain the phenotypic
similarities between genders and would be consonant
with the finding of exclusively de novo mutations, which
could occur in germline or somatic tissues. Males with
germline mutations are probably nonviable; males and
females with somatic mutations manifest a phenotype
that is most likely determined by the stage of development
at the time of mutation and by the tissue distribution ofThe American Joumutated cells. Females might harbor germline or somatic
mutations. A further corollary is that more and less severe
phenotypes are likely to be found in males on the basis
of whether somatic mutations occur earlier or later in
embryogenesis, respectively. This pattern has been ob-
served in Rett syndrome (MIM 312750), another X-linked
dominant disorder.8 Females could also present with
milder phenotypes if they harbor a later somatic mutation.
In support of this mechanism, sequencing of DNA from
the blood of the second male identified two WDR45
exon 12 amplicons (one wild-type and one deleted with
discrepant peak amplitudes; see Figure 3), which would
be seen if there were two different populations of DNA
molecules, as in the case of somatic mosaicism. Genetic
analysis of multiple tissues might be necessary for identi-
fying WDR45 mutations in mildly affected individuals.
To also help explain the phenotypic similarity between
males and females, we found evidence to suggest skew-
ing of X chromosome inactivation. Using established
methods9 to analyze peripheral blood from 12 women
with mutations in WDR45, we rated the X-inactivationrnal of Human Genetics 91, 1144–1149, December 7, 2012 1147
Figure 3. Evidence for Somatic Mutation
A sequencing electropherogram from male subject 463 shows two DNA traces of differing peak amplitudes to the right of the arrow.pattern as random in two subjects (50:50 to 75:25), skewed
in six subjects (75:25 to 90:10), and extremely skewed in
four subjects (>90:10). Although these results suggest
that a skewed methylation pattern might contribute to
disease pathogenesis, more detailed studies will be needed
for determining whether the mutated allele is preferen-
tially inactivated and whether patterns in peripheral blood
reflect those in the brain in this disorder.
Despite clear evidence of a causal role for mutations in
WDR45 in this phenotype with prominent parkinsonism,
Xp11.23 has not been reported as a PARK locus. Predict-
ably, both linkage and association studies would lack signal
because of the combination of de novo mutations and low
reproductive fitness of those affected. Given the pheno-
type, we propose WDR45 as a PARK gene. As with other
forms of NBIA, the phenotypic spectrum associated with
mutations in WDR45 is likely to broaden and to include
other parkinsonism syndromes as more individuals are
screened.
In conclusion, we have identified mutations in WDR45
as a cause of a distinctive X-linked dominant form of
NBIA. De novo mutations in this gene underlie a
phenotype of childhood developmental disability with
adolescent or adult onset of dystonia, parkinsonism, and
dementia. In keeping with the naming convention of
other forms of NBIA (PKAN, PLAN, MPAN), we propose
the term ‘‘beta-propeller protein-associated neurodegener-
ation’’ (BPAN) for the disease associated with mutations in
WDR45. We recommend that the previously referenced
term ‘‘SENDA’’ (static encephalopathy of childhood with
neurodegeneration in adulthood) no longer be used1–3
(see also GeneReviews in Web Resources). Our under-
standing of the pathogenesis of BPAN will increase with
further investigation of typical, as well as atypical, affected
persons who challenge the usual pattern of X-linked
disease.Supplemental Data
Supplemental Data include two tables and can be found with this
article online at http://www.cell.com/AJHG.1148 The American Journal of Human Genetics 91, 1144–1149, DeceAcknowledgments
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